{
  "schema_version": "G3_2.2.3e",
  "ticker": "ZENV",
  "company_name": "Zenvia Inc.",
  "reporting_currency": "BRL",
  "analysis_date": "2025-12-23",

  "discount_rate_calculation": {
    "formula": "RFR + (ERP × X)",
    "components": {
      "RFR": {
        "value": 0.126,
        "unit": "percentage",
        "source": "Brazil 10-year government bond yield",
        "note": "Brazilian risk-free rate as of Dec 2025; reflects sovereign inflation and credit risk"
      },
      "ERP": {
        "value": 0.065,
        "unit": "percentage",
        "source": "Global equity risk premium (Damodaran 2025)",
        "note": "Mature market ERP ~6.5%; applied to local RFR for emerging market company"
      },
      "X": {
        "value": 1.45,
        "unit": "beta multiplier",
        "calibration_rationale": "B.3 rubric calibration for small-cap EM ADR in transition",
        "note": "See detailed rubric scoring below"
      }
    },
    "discount_rate_BRL": {
      "value": 0.220,
      "unit": "percentage",
      "calculation": "12.6% + (6.5% × 1.45) = 22.0%",
      "note": "BRL-denominated discount rate for local cash flows"
    },
    "discount_rate_USD": {
      "value": 0.155,
      "unit": "percentage",
      "calculation": "4.5% + (6.5% × 1.45) = 14.9%, rounded to 15.5% for currency risk",
      "note": "USD-denominated rate for ADR valuation; assumes ~350 bps BRL/USD differential converges over forecast period"
    }
  },

  "B3_rubric_calibration": {
    "description": "Systematic calibration of beta multiplier X ∈ [0.5, 2.0] using B.3 rubric dimensions",
    "dimensions": [
      {
        "factor": "Company Size",
        "score": 1.8,
        "rationale": "Market cap ~USD 56MM (BRL 326MM). Micro-cap by US standards, small-cap in Brazil. Illiquid trading (avg volume 35K shares). Scores near max on size risk.",
        "reference_range": "0.5 = large-cap (>$10B), 2.0 = micro-cap (<$100MM)"
      },
      {
        "factor": "Geographic Risk",
        "score": 1.6,
        "rationale": "82% revenue Brazil (EM), 14% USA. Argentina subsidiary in hyperinflationary economy. Currency exposure (BRL/USD volatility). Above-average EM risk but not frontier market.",
        "reference_range": "0.5 = DM-only, 2.0 = frontier/high-risk EM"
      },
      {
        "factor": "Business Model Stability",
        "score": 1.7,
        "rationale": "In midst of strategic pivot from CPaaS/SaaS mix to SaaS-only. CPaaS revenue declining with margin erosion. SaaS unproven at scale. High execution uncertainty.",
        "reference_range": "0.5 = stable recurring model, 2.0 = turnaround/pivot"
      },
      {
        "factor": "Financial Health",
        "score": 1.9,
        "rationale": "Negative working capital BRL -444MM, going concern risk acknowledged. Covenant breaches requiring waivers. Net debt BRL 60MM + BRL 271MM acquisition liabilities vs BRL 88MM EBITDA. Dependent on asset sale to avoid distress.",
        "reference_range": "0.5 = fortress balance sheet, 2.0 = distressed/going concern"
      },
      {
        "factor": "Competitive Position",
        "score": 1.4,
        "rationale": "CPaaS: weak position in commoditized market, margins collapsing. SaaS: early mover in Brazil CX but facing global competitors (Salesforce, HubSpot). Modest competitive moat.",
        "reference_range": "0.5 = dominant moat, 2.0 = commodity/no moat"
      },
      {
        "factor": "Management & Governance",
        "score": 1.5,
        "rationale": "Founder-CEO aligned but recent CFO change, CHRO/CTO departures. Controlling shareholders (Bobsin/Oria) supportive but also potentially conflicted. Execution track record mixed (successful M&A integration but margin miss).",
        "reference_range": "0.5 = exemplary governance, 2.0 = major red flags"
      },
      {
        "factor": "Growth Stage",
        "score": 1.3,
        "rationale": "Mature CPaaS business (declining). SaaS in early scaling phase (23% growth). Not startup but not mature. Moderate growth risk.",
        "reference_range": "0.5 = mature/stable growth, 2.0 = pre-revenue/hyper-growth"
      },
      {
        "factor": "Earnings Quality",
        "score": 1.6,
        "rationale": "EBITDA positive but gross margin compressed. Revenue mix volatile. Heavy adjustments (normalized EBITDA excludes earn-out, severance). Tax loss carryforwards mask cash tax reality. Moderate earnings quality issues.",
        "reference_range": "0.5 = high-quality recurring, 2.0 = low-quality/non-recurring"
      }
    ],
    "aggregate_score": {
      "raw_average": 1.60,
      "adjustments": [
        {
          "factor": "Liquidity crisis override",
          "adjustment": 0.10,
          "rationale": "Going concern risk and covenant breaches warrant additional premium beyond financial health score"
        },
        {
          "factor": "Strategic pivot risk",
          "adjustment": 0.05,
          "rationale": "Execution risk of CPaaS exit and SaaS scaling warrants incremental premium"
        },
        {
          "factor": "Small EM company discount",
          "adjustment": -0.30,
          "rationale": "Double-counting risk: size and geography already scored high; avoid over-penalizing. X should be elevated but not punitive."
        }
      ],
      "calibrated_X": 1.45,
      "confidence": "MEDIUM",
      "note": "Raw average 1.60 + adjustments (+0.10 liquidity, +0.05 pivot, -0.30 double-count) = 1.45. This reflects elevated risk profile (small EM ADR in transition with liquidity stress) but not distressed/terminal level."
    }
  },

  "discount_rate_sensitivities": {
    "description": "Sensitivity of DR to X calibration and component assumptions",
    "X_sensitivity": [
      {"X": 1.20, "DR_BRL": 0.204, "note": "Lower risk case (successful pivot executed cleanly)"},
      {"X": 1.45, "DR_BRL": 0.220, "note": "Base case"},
      {"X": 1.70, "DR_BRL": 0.237, "note": "Higher risk case (pivot stumbles, liquidity worsens)"}
    ],
    "RFR_sensitivity": [
      {"RFR": 0.110, "DR_BRL": 0.204, "note": "Brazil yields compress 160 bps"},
      {"RFR": 0.126, "DR_BRL": 0.220, "note": "Base case"},
      {"RFR": 0.140, "DR_BRL": 0.234, "note": "Brazil yields rise 140 bps"}
    ],
    "note": "DR most sensitive to X calibration (business-specific risk) and Brazil RFR (sovereign/inflation risk). ERP assumed stable at 6.5%."
  },

  "validation_checks": {
    "WACC_comparison": {
      "implied_equity_cost": 0.220,
      "debt_cost": 0.18,
      "debt_to_capital": 0.35,
      "WACC_estimate": 0.206,
      "note": "Implied WACC ~20.6% consistent with elevated risk profile. Post-divestiture WACC would decline to ~16-18% as leverage normalizes and business model stabilizes."
    },
    "peer_comparison": {
      "global_SaaS_median_WACC": 0.10,
      "LatAm_tech_median_WACC": 0.15,
      "ZENV_premium_to_LatAm": 0.07,
      "rationale": "ZENV DR 22% vs LatAm tech median ~15%. 700 bps premium justified by: (1) micro-cap illiquidity, (2) going concern risk, (3) strategic transition execution risk. Peers (MercadoLibre, VTEX, STNE) are larger, more established, better capitalized."
    },
    "reasonableness_check": {
      "terminal_growth_assumption": 0.045,
      "implied_perpetuity_multiple": 15.0,
      "note": "DR 22% - terminal growth 4.5% = 17.5% perpetuity discount = ~5.7x EV/EBITDA terminal multiple. Reasonable for small EM SaaS company if pivot succeeds."
    }
  },

  "recommendation": {
    "discount_rate_BRL": 0.220,
    "discount_rate_USD": 0.155,
    "confidence_level": "MEDIUM",
    "rationale": "22% BRL DR reflects elevated risk profile across all dimensions: micro-cap, EM exposure, strategic pivot, liquidity stress, competitive uncertainty. X=1.45 calibrated systematically via B.3 rubric, landing in 1.2-1.5 range expected for small EM/ADR companies. DR will likely decline to 18-19% post-divestiture if pivot succeeds (improved financial health, simplified business model, larger equity cushion). Current DR appropriate for valuing uncertain transition period cash flows.",
    "key_sensitivities": [
      "X calibration (business-specific risk): ±0.25 moves DR by ±160 bps",
      "Brazil RFR (sovereign/inflation): ±140 bps moves DR by ±140 bps",
      "Strategic pivot success: Could justify DR reduction to 18% by 2027-2028"
    ],
    "usage_notes": [
      "Apply 22% BRL DR to BRL-denominated cash flows in GIM forecast",
      "Consider 15.5% USD DR for cross-check using translated cash flows",
      "Re-calibrate X to 1.2-1.3 range post-CPaaS divestiture for terminal value",
      "Sensitivity analysis should span 18-26% DR range given execution uncertainty"
    ]
  }
}
